Testing effectiveness (Phase 2)Study completedNCT06717815
What this trial is testing
Phase IIa Study for IPG11406 in Patients With Lupus Nephritis
Who this might be right for
Lupus Nephritis
Nanjing Immunophage Biotech Co., Ltd 24
Showing 20 of 0 results